Cary, NC, United States of America

Jie Li

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie Li. Retrieved from https://idiyas.com/inventor/jie-li-m8gevj0w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jie Li

Introduction

Jie Li is an accomplished inventor based in Cary, NC, with a focus on developing innovative polymeric derivatives. He holds two patents that contribute significantly to the field of drug delivery systems. His work aims to enhance the efficacy of amino-containing drugs through advanced polymeric technology.

Latest Patents

Jie Li's latest patents include the development of polymeric benzyl carbonate-derivatives. These inventions relate to polymeric derivatives that can be conjugated to amino-containing drugs, improving their in vivo properties. The polymeric derivative can be released to yield the drug in its native form, providing a novel approach to drug delivery. Methods for preparing and utilizing these polymeric derivatives and drug conjugates are also described in his patents.

Career Highlights

Throughout his career, Jie Li has worked with notable companies such as Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has allowed him to refine his expertise in the field of pharmaceuticals and drug delivery systems.

Collaborations

Some of Jie Li's coworkers include Guohan Yang and Ton That Hai, who have collaborated with him on various projects related to his inventions.

Conclusion

Jie Li's contributions to the field of drug delivery through his innovative polymeric derivatives demonstrate his commitment to advancing medical technology. His patents reflect a significant step forward in improving the effectiveness of drug therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…